Biolidics to launch Covid-19 rapid test kit in April
Singapore
CANCER-diagnostics company Biolidics on Monday announced that it has launched a rapid test kit for Covid-19, which is expected to be available by the end of April.
Biolidics said its novel corona-virus test can detect Covid-19 using serum, plasma or whole blood samples with an accuracy of more than 95 per cent in 10 minutes, and has received provisional authorisation from Singapore's Health Sciences Authority for use here.
TRENDING NOW
Changes to EV incentives, uncertainty over COE framework drive Category A premium to a new high in ‘re-run of 2025 mania’
Employers want AI-fluent employees. Hiring them is the challenge
What makes a good job? Feeling that you matter
Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects